Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.

Lin YJ, Lin IC, Yu HR, Kuo HC, Yang KD, Chang WC, Liang CD, Liu SF, Kuo HC.

Pediatr Cardiol. 2013 Feb;34(2):250-5. doi: 10.1007/s00246-012-0429-y. Epub 2012 Jul 19.

PMID:
22810044
2.

Kawasaki disease in a pediatric intensive care unit: a case-control study.

Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP.

Pediatrics. 2008 Oct;122(4):e786-90. doi: 10.1542/peds.2008-1275. Epub 2008 Sep 22.

PMID:
18809597
3.

High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.

Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.

PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603. eCollection 2015.

4.

[Kawasaki disease: what you need to know].

Bajolle F, Laux D.

Arch Pediatr. 2012 Nov;19(11):1264-8. doi: 10.1016/j.arcped.2012.07.005. Epub 2012 Aug 24. Review. French.

PMID:
22921712
5.

Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A.

Pediatr Cardiol. 2013 Aug;34(6):1476-81. doi: 10.1007/s00246-013-0673-9. Epub 2013 Mar 6.

PMID:
23463134
7.

Assessment of risk factors for Korean children with Kawasaki disease.

Kim JJ, Hong YM, Yun SW, Han MK, Lee KY, Song MS, Lee HD, Kim DS, Sohn S, Ha KS, Hong SJ, Kim KJ, Park IS, Jang GY, Lee JK; Korean Kawasaki Disease Genetics Consortium.

Pediatr Cardiol. 2012 Apr;33(4):513-20. doi: 10.1007/s00246-011-0143-1. Epub 2011 Nov 22.

PMID:
22105492
8.

Ulinastatin therapy in kawasaki disease.

Iwashima S, Seguchi M, Matubayashi T, Ohzeki T.

Clin Drug Investig. 2007;27(10):691-6.

PMID:
17803344
9.

Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.

Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B.

Asian Pac J Allergy Immunol. 2006 Mar;24(1):27-32.

10.

Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.

Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.

Eur J Pediatr. 2009 Nov;168(11):1315-21. doi: 10.1007/s00431-009-0925-0. Epub 2009 Jan 22.

PMID:
19159953
11.

Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.

Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.

Pediatrics. 2004 Dec;114(6):e689-93. Epub 2004 Nov 15.

PMID:
15545617
12.

Infections and Kawasaki disease: implications for coronary artery outcome.

Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.

Pediatrics. 2005 Dec;116(6):e760-6.

PMID:
16322132
13.

Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.

Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.

Pediatr Cardiol. 2003 Mar-Apr;24(2):122-6. Epub 2002 Dec 4.

PMID:
12457252
14.

Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.

Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.

Kaohsiung J Med Sci. 2012 Jan;28(1):23-9. doi: 10.1016/j.kjms.2011.09.002. Epub 2011 Dec 11.

15.

Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.

Singh-Grewal D, Wong M, Isaacs D.

J Paediatr Child Health. 2005 Sep-Oct;41(9-10):495-9.

PMID:
16150066
16.

Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.

Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.

J Microbiol Immunol Infect. 2007 Oct;40(5):395-400.

PMID:
17932598
17.

[Risk factors for coronary artery lesions in children with Kawasaki disease].

Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.

Zhongguo Dang Dai Er Ke Za Zhi. 2012 Dec;14(12):938-41. Chinese.

18.

Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.

Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.

J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):348-50, 370.

PMID:
16201293
19.

Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.

Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.

Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.

20.

Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.

Chen CJ, Huang FC, Tiao MM, Huang YH, Lin LY, Yu HR, Yang KD, Huang YC, Chen CC, Chang WC, Kuo HC.

ScientificWorldJournal. 2012;2012:485758. doi: 10.1100/2012/485758. Epub 2012 Jun 18.

Items per page

Supplemental Content

Write to the Help Desk